These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1370518)

  • 1. Relationship between cytokine-dependent cell cycle progression and MHC class II antigen expression by human CD34+ HLA-DR- bone marrow cells.
    Srour EF; Brandt JE; Leemhuis T; Ballas CB; Hoffman R
    J Immunol; 1992 Feb; 148(3):815-20. PubMed ID: 1370518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid exit from G0/G1 phases of cell cycle in response to stem cell factor confers on umbilical cord blood CD34+ cells an enhanced ex vivo expansion potential.
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Srour EF
    Exp Hematol; 1994 Dec; 22(13):1264-72. PubMed ID: 7525328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
    Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
    Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD34+ HLA-DR- bone marrow cells contain progenitor cells capable of self-renewal, multilineage differentiation, and long-term in vitro hematopoiesis.
    Srour EF; Brandt JE; Briddell RA; Leemhuis T; van Besien K; Hoffman R
    Blood Cells; 1991; 17(2):287-95. PubMed ID: 1717081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin-11 stimulates the proliferation of human hematopoietic CD34+ and CD34+CD33-DR- cells and synergizes with stem cell factor, interleukin-3, and granulocyte-macrophage colony-stimulating factor.
    Lemoli RM; Fogli M; Fortuna A; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1993 Dec; 21(13):1668-72. PubMed ID: 7694867
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta regulates the cell cycle status of interleukin-3 (IL-3) plus IL-1, stem cell factor, or IL-6 stimulated CD34+ human hematopoietic progenitor cells through different cell kinetic mechanisms depending on the applied stimulus.
    Lardon F; Snoeck HW; Nijs G; Lenjou M; Peetermans ME; Rodrigus I; Berneman ZN; Van Bockstaele DR
    Exp Hematol; 1994 Aug; 22(9):903-9. PubMed ID: 7520393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytokine-dependent long-term culture of highly enriched precursors of hematopoietic progenitor cells from human bone marrow.
    Brandt J; Srour EF; van Besien K; Briddell RA; Hoffman R
    J Clin Invest; 1990 Sep; 86(3):932-41. PubMed ID: 1697607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recombinant interleukin 3 induces interleukin 2 receptor expression on early myeloid cells in normal human bone marrow.
    Gazzola MV; Collins NH; Tafuri A; Keever CA
    Exp Hematol; 1992 Feb; 20(2):201-8. PubMed ID: 1371965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stem cell factor (c-kit ligand) enhances the interleukin-9-dependent proliferation of human CD34+ and CD34+CD33-DR- cells.
    Lemoli RM; Fortuna A; Fogli M; Motta MR; Rizzi S; Benini C; Tura S
    Exp Hematol; 1994 Aug; 22(9):919-23. PubMed ID: 7520394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Steel factor supports the cycling of isolated human CD34+ cells in the absence of other growth factors.
    Gore SD; Amin S; Weng LJ; Civin CI
    Exp Hematol; 1995 May; 23(5):413-21. PubMed ID: 7536683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maintenance of hematopoiesis in serum-free bone marrow cultures involves sequential recruitment of quiescent progenitors.
    Lansdorp PM; Dragowska W
    Exp Hematol; 1993 Sep; 21(10):1321-7. PubMed ID: 7689481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential regulation of the expression of CD38 and human leukocyte antigen-DR on CD34+ hematopoietic progenitor cells by interleukin-4 and interferon-gamma.
    Snoeck HW; Lardon F; Lenjou M; Nys G; Van Bockstaele DR; Peetermans ME
    Exp Hematol; 1993 Oct; 21(11):1480-6. PubMed ID: 7691636
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of mast cell growth factor, interleukin-3, and interleukin-6 on human primitive hematopoietic progenitors from bone marrow and cord blood.
    Tsujino Y; Wada H; Misawa M; Kai S; Hara H
    Exp Hematol; 1993 Sep; 21(10):1379-86. PubMed ID: 7689484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions of tumor necrosis factor with granulocyte-macrophage colony-stimulating factor and other cytokines in the regulation of dendritic cell growth in vitro from early bipotent CD34+ progenitors in human bone marrow.
    Reid CD; Stackpoole A; Meager A; Tikerpae J
    J Immunol; 1992 Oct; 149(8):2681-8. PubMed ID: 1383322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recombinant GM-CSF/IL-3 fusion protein: its effect on in vitro human megakaryocytopoiesis.
    Bruno E; Briddell RA; Cooper RJ; Brandt JE; Hoffman R
    Exp Hematol; 1992 May; 20(4):494-9. PubMed ID: 1373690
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapy.
    Fruehauf S; Veldwijk MR; Krämer A; Haas R; Zeller WJ
    Stem Cells; 1998; 16(4):271-9. PubMed ID: 9708449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of early hematopoiesis in serum-deprived cultures of mafosfamide-treated and untreated CD34-enriched bone marrow cells.
    Ottmann OG; Stella CC; Eder M; Reutzel P; Ströcker S; Hoelzer D; Ganser A
    Exp Hematol; 1991 Sep; 19(8):773-8. PubMed ID: 1714403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of interleukin-4 on myelopoiesis: localization of the action of IL-4 in the CD34+HLA-DR++ subset and distinction between direct and indirect effects of IL-4.
    Snoeck HW; Lardon F; Van Bockstaele DR; Peetermans ME
    Exp Hematol; 1993 May; 21(5):635-9. PubMed ID: 7685706
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human interleukin (IL)-9 specifically stimulates proliferation of CD34+++DR+CD33- erythroid progenitors in normal human bone marrow in the absence of serum.
    Lu L; Leemhuis T; Srour EF; Yang YC
    Exp Hematol; 1992 May; 20(4):418-24. PubMed ID: 1373687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.